SERPINE1 and colorectal carcinoma: Functional inhibition of SERPINE1, either using shRNA or pharmacological inhibitors like tiplaxtinin, resensitized resistant cells to oxaliplatin and reduced metastatic potential, establishing SERPINE1 as a key player in oxaliplatin resistance-induced metastasis in CRC.